Meron Capital ^Investors

Meron Capital is an early stage venture capital fund based in Tel Aviv, Israel. Founded on December 1, 2016, Meron focuses on investing in strong founders who are developing core software technologies. While primarily operating in Israel, Meron also has a presence in Europe, the Middle East, and Africa (EMEA) regions. In the field of biotech, pharma, and Biomed, Meron has invested in companies like Immunai, a leading player in the field of single-cell genomics and immune profiling.